Penelope R. A. Taylor

1.9k total citations
34 papers, 1.4k citations indexed

About

Penelope R. A. Taylor is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Penelope R. A. Taylor has authored 34 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 11 papers in Oncology and 9 papers in Genetics. Recurrent topics in Penelope R. A. Taylor's work include Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Viral-associated cancers and disorders (7 papers). Penelope R. A. Taylor is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Viral-associated cancers and disorders (7 papers). Penelope R. A. Taylor collaborates with scholars based in United Kingdom, Nigeria and United States. Penelope R. A. Taylor's co-authors include Stephen J. Proctor, Graham Jackson, Anne M. Dickinson, Peter G. Middleton, P. W. G. Saunders, Brian Angus, Annette Neylon, Martin Howard, G Stark and James Cavet and has published in prestigious journals such as Blood, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Penelope R. A. Taylor

34 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Penelope R. A. Taylor United Kingdom 19 639 524 451 421 190 34 1.4k
Maurizio Musso Italy 19 702 1.1× 334 0.6× 277 0.6× 364 0.9× 243 1.3× 68 1.4k
Irena Sniecinski United States 22 1.1k 1.7× 339 0.6× 375 0.8× 510 1.2× 281 1.5× 49 1.8k
K Kawa Japan 21 677 1.1× 506 1.0× 646 1.4× 715 1.7× 139 0.7× 51 1.6k
Alessandra Sperotto Italy 22 966 1.5× 293 0.6× 418 0.9× 378 0.9× 343 1.8× 55 1.5k
PJ Bierman United States 17 678 1.1× 690 1.3× 261 0.6× 724 1.7× 308 1.6× 24 1.4k
Esteban Abella United States 17 551 0.9× 225 0.4× 233 0.5× 512 1.2× 155 0.8× 56 1.3k
Daniele Laszlò Italy 20 597 0.9× 649 1.2× 223 0.5× 709 1.7× 350 1.8× 67 1.6k
Toshiki Yamada Japan 18 441 0.7× 310 0.6× 274 0.6× 336 0.8× 249 1.3× 61 1.1k
Eefke Petersen Netherlands 21 924 1.4× 270 0.5× 450 1.0× 446 1.1× 251 1.3× 69 1.7k
Diane Coso France 25 929 1.5× 376 0.7× 309 0.7× 582 1.4× 318 1.7× 78 1.7k

Countries citing papers authored by Penelope R. A. Taylor

Since Specialization
Citations

This map shows the geographic impact of Penelope R. A. Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Penelope R. A. Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Penelope R. A. Taylor more than expected).

Fields of papers citing papers by Penelope R. A. Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Penelope R. A. Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Penelope R. A. Taylor. The network helps show where Penelope R. A. Taylor may publish in the future.

Co-authorship network of co-authors of Penelope R. A. Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Penelope R. A. Taylor. A scholar is included among the top collaborators of Penelope R. A. Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Penelope R. A. Taylor. Penelope R. A. Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Khan, Gulfaraz, Annette Lake, Lesley Shield, et al.. (2005). Phenotype and frequency of Epstein–Barr virus‐infected cells in pretreatment blood samples from patients with Hodgkin lymphoma. British Journal of Haematology. 129(4). 511–519. 17 indexed citations
3.
Cordano, Pablo, Annette Lake, Lesley Shield, et al.. (2005). Effect of IL‐6 promoter polymorphism on incidence and outcome in Hodgkin's lymphoma. British Journal of Haematology. 128(4). 493–495. 33 indexed citations
4.
Mainou‐Fowler, Tryfonia, Brian Angus, Susan A. Miller, et al.. (2005). Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PdEGF) in classical Hodgkin lymphoma (HL). Leukemia & lymphoma. 47(2). 223–230. 29 indexed citations
5.
Summerfield, Geoffrey, et al.. (2004). Survival in Young Patients (Less than 40 Years) with Follicular Lymphoma: A population Based Study by the Scotland and Newcastle Lymphoma Group. Leukemia & lymphoma. 45(6). 1149–1157. 6 indexed citations
7.
Neylon, Annette, et al.. (2003). Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population‐based cohort of 245 patients. British Journal of Haematology. 122(6). 966–974. 248 indexed citations
9.
Summerfield, Geoffrey, et al.. (2002). High‐dose chlorambucil for the treatment of chronic lymphocytic leukaemia and low‐grade non‐Hodgkin's lymphoma. British Journal of Haematology. 116(4). 781–786. 15 indexed citations
11.
Stark, G, Katrina Wood, Fergus Jack, et al.. (2002). Hodgkin's disease in the elderly: a population‐based study. British Journal of Haematology. 119(2). 432–440. 118 indexed citations
12.
Mainou‐Fowler, Tryfonia, Helen Dignum, Penelope R. A. Taylor, et al.. (2002). Quantification improves the prognostic value of CD38 expression in B‐cell chronic lymphocytic leukaemia. British Journal of Haematology. 118(3). 755–761. 27 indexed citations
13.
Mainou‐Fowler, Tryfonia, et al.. (2000). Tumour Necrosis Factor Gene Polymorphisms in Lymphoproliferative Disease. Leukemia & lymphoma. 38(5-6). 547–552. 20 indexed citations
14.
Galloway, M J, et al.. (1999). Implementing clinical governance in the united kingdom: the role of a regional haematology group. British Journal of Haematology. 107(4). 680–684. 3 indexed citations
15.
Dickinson, Anne M., Lisbet Sviland, Xiao N. Wang, et al.. (1998). PREDICTING GRAFT-VERSUS-HOST DISEASE IN HLA-IDENTICAL BONE MARROW TRANSPLANTS. Transplantation. 66(7). 857–863. 28 indexed citations
17.
Maung, Z. T., M M Reid, Elizabeth Matheson, et al.. (1995). Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia. British Journal of Haematology. 91(1). 93–100. 31 indexed citations
18.
Howard, M. R., Penelope R. A. Taylor, & S.J. Proctor. (1995). Oral Idarubicin in Haematological Malignancy. Clinical Drug Investigation. 9(Supplement 2). 16–28. 4 indexed citations
19.
Linch, David C., S.J. Proctor, Rajesh Chopra, et al.. (1993). Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation.. PubMed. 11(4). 307–11. 66 indexed citations
20.
Maung, Z. T., et al.. (1993). Patient Education for Self-Referral and On-Demand Treatment for Herpes Zoster in Lymphoma Patients. Leukemia & lymphoma. 11(5-6). 447–452. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026